Brief: Intra-Cellular Therapies Inc- On Dec 19, Co's Unit, ITI Limited Entered Amendment No.1 To Master Services Agreement Dated As Of January 10, 2017
Dec 22 (Reuters) - Intra-Cellular Therapies Inc
ITCI.O :
* INTRA-CELLULAR THERAPIES INC-ON DEC 19, 2022, CO'S UNIT,
ITI
LIMITED ENTERED AMENDMENT NO. 1 TO MASTER SERVICES AGREEMENT
DATED AS OF JANUARY 10, 2017
* INTRA-CELLULAR THERAPIES INC - AMENDMENT EXTENDS CURRENT
TERM OF
MSA UNTIL DECEMBER 31, 2028
* INTRA-CELLULAR THERAPIES INC-AMENDMENT PROVIDES MINIMUM
ANNUAL
PURCHASE COMMITMENTS BY CO FOR YEARS 2025 THROUGH 2028 FOR
LONZA’S MANUFACTURE OF CAPLYTA
Further company coverage: ITCI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Intra-Cellular Therapies
See all newsBrief: Intra-Cellular Therapies stockholder filed lawsuit against co, board in NY Supreme Court
Intra-Cellular Therapies Inc reports results for the quarter ended December 31 - Earnings Summary
U.S. RESEARCH ROUNDUP-Apple, Caterpillar, Visa
Street View: New drug launches, ITCI deal to boost J&J's growth
J&J beats quarterly sales and profit estimates on cancer drug sales (updated)